Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$16.7K Sell
47
-104
-69% -$37.1K 0.01% 287
2025
Q4
$49.5K Buy
151
+101
+202% +$32K 0.03% 174
2025
Q3
$14K Buy
50
+5
+11% +$1.45K 0.01% 324
2025
Q2
$12.7K Hold
45
0.01% 282
2025
Q1
$14K Hold
45
0.01% 296
2024
Q4
$12.7K Buy
+45
New +$13.4K 0.01% 261

Other funds holding AMGN

Hurley Capital's AMGN Position: Q1 2026 in Review

Hurley Capital reduced its Amgen (AMGN) stake by 69% in Q1 2026, selling an estimated $37.1K and leaving 47 shares worth $16.7K. The position accounts for 0.01% of the portfolio, ranked #287.

Hurley Capital first reported a position in AMGN in Q4 2024 and has held it in 6 quarters since. The position peaked at $49.5K in Q4 2025. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Hurley Capital held 47 shares of Amgen worth $16.7K as of Q1 2026.
  • Hurley Capital sold 104 Amgen shares in Q1 2026, an estimated $37.1K.
  • Amgen made up 0.01% of Hurley Capital's portfolio in Q1 2026, its #287 holding.
  • Hurley Capital first reported a position in Amgen in Q4 2024 and has held it in 6 quarters since.
  • Hurley Capital's Amgen position peaked at $49.5K in Q4 2025.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Hurley Capital's 13F filing for Q1 2026, filed 6 May 2026.